Balance Sheet for Cyclerion Therapeutics Inc. (CYCN)

$ 2.50   -0.08 (-3.10%) Volume: 772.75k 4:00 PM EDT Oct 27, 2020
After Hours:  $ 2.53   0.03 (+1.20%) Volume: 5.57k 7:55 PM EDT Oct 27, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017
Cash and Equivalents 94,895 - -
Restrictable Cash - - -
Marketable Securities - - -
Accounts Receivable 1,474 - -
Loans Receivable - - -
Other Receivables - - -
Receivables 1,474 - -
Inventories, Raw Materials - - -
Inventories, Work in Progress - - -
Inventories, Purchased Components - - -
Inventories, Finished Goods - - -
Inventories, Other - - -
Inventories, Adjustments & Allowances - - -
Inventories - - -
Prepaid Expenses 1,966 867 1,251
Current Deferred Income Taxes - - -
Other Current Assets 2,862 12 8
Total Current Assets 101,197 879 1,259
Land and Improvements - - -
Buildings and Improvement 81,810 - -
Machinery, Furniture and Equipment 18,627 21,247 19,863
Construction in Progress 915 741 137
Fixed Assets, Other - - -
Fixed Assets, Total 101,352 21,988 20,000
Gross Fixed Assets 101,352 21,988 20,000
Accumulated Depreciation (21,602) (15,491) (15,869)
Net Fixed Assets 79,750 6,497 4,131
Intangibles - - -
Cost in Excess - - -
Non-Current Deferred Income Taxes - - -
Other Non-Current Assets 5,531 25 80
Total Non-Current Assets 85,281 6,522 4,211
Total Assets 186,478 7,401 5,470
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017
Accounts Payable 3,311 2,781 1,802
Short Term Debt 3,420 - -
Notes Payable - - -
Accrued Expenses 5,338 8,841 7,858
Accrued Liabilities 5,338 8,841 7,858
Deferred Revenues - - -
Current Deferred Income Taxes - - -
Other Current Liabilities 6,180 6,224 4,377
Total Current Liabilities 18,249 17,846 14,037
Long Term Debt N/A N/A N/A
Deferred Income Tax - - -
Other Non-Current Liabilities - - -
Minority Interest - - -
Capital Lease Obligations 70,500 - -
Preferred Securities of Subsidiary Trust - - -
Preferred Equity Outside Shareholders' Equity - - -
Total Non-Current Liabilities 70,500 - -
Total Liabilities 88,749 17,846 14,037
Preferred Shareholder's Equity - - -
Common Shareholder's Equity 97,729 (10,445) (8,567)
Common Par - - -
Additional Paid in Capital 183,376 - -
Cumulative Translation Adjustments - - -
Retained Earnings (85,627) - -
Treasury Stock - - -
Other Equity Adjustments (20) - -
Total Capitalization 97,729 (10,445) (8,567)
Total Equity 97,729 (10,445) (8,567)
Total Liabilities & Shareholder's Equity 186,478 7,401 5,470
Cash Flow (123,007) (115,252) (93,922)
Working Capital 82,948 (16,967) (12,778)
Free Cash Flow (109,103) (100,941) (82,622)
Invested Capital 97,729 (10,445) (8,567)
Shares Outstanding - Common Class Only 27,598 - -
Preferred Shares Outstanding - - -
Total Ordinary Shares 27,598 27,411 27,304
Total Common Shares Outstanding 27,598 - -
Treasury Shares - - -
Basic Weighted Shares Outstanding 27,380 27,304 27,304
Diluted Weighted Shares Outstanding 27,380 27,304 27,304